Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 24 2017

Full Issue

Proposed Gutting Of Drug Czar's Funding Rolled Back To Just Trims After Vocal Outcry

A draft of the president's budget had shown a proposed 95 percent cut to the office in the middle of an opioid epidemic. But the released plan walks that back. Meanwhile, Food and Drug Administration Commissioner Scott Gottlieb is calling on his staff to increase efforts to fight the crisis sweeping the country.

Stat: After Outcry, Trump Budget Largely Preserves 'Drug Czar' Funding

After an outcry, the Trump administration has rolled back a proposed gutting of the Office of National Drug Control Policy, instead asking for relatively small trims to the office and largely preserving two main grant programs. President Trump’s 2018 budget — released Tuesday — is just a proposal; Congress actually allocates government spending. (Joseph, 5/23)

Morning Consult: Trump Drops Plan To Gut Drug Czar’s Office Budget

The administration’s final budget proposal, released Tuesday, continues funding for the office, which oversees two key national anti-drug programs. A document leaked earlier this month proposed cutting funding for the program by 95 percent. (Reid, 5/23)

CQ Roll Call: Drug Office Cuts Rolled Back As FDA Examines Opioid Policies

Lawmakers in states where opioid abuse is rampant praised the Office of Management and Budget for not proceeding with the original cuts. “I’m happy to see OMB reversed course and included funding for the office in its budget,” said Sen. Shelley Moore Capito, R-W.Va., a member of the Appropriations Committee. "We still have a long way to go when it comes to the drug epidemic, and it is essential that we remain fully committed to fighting it. We need to be doing more — not less.” (Siddons, 5//23)

The Washington Post: FDA Commissioner Gottlieb Calls For ‘More Forceful Steps’ To Curb Opioid Epidemic

Food and Drug Commissioner Scott Gottlieb called on his staff Tuesday to explore “more forceful” efforts to curb the epidemic, including requiring training for doctors and ensuring patients aren't prescribed the medications for unnecessarily long periods that increase the risk of addiction. “Opioid prescriptions should be written only for appropriate patients and for appropriate durations,” Gottlieb said in his first interview since becoming commissioner. “No more 30-day supplies for tooth extractions” or uncomplicated hernia repairs. (McGinley, 5/23)

And in opioid news from the states —

The Associated Press: NY Senate Heroin Task Force To Hear From Experts, Ex-Users

New York lawmakers working to address the heroin and opioid epidemic want to hear from the experts — and people with first-hand experience with addiction. A state Senate Task Force is holding a public hearing Wednesday at the Fulton-Montgomery Community College in Johnstown. (5/24)

Arizona Republic: Attorney General Works With CVS To Make Anti-Overdose Drug Available

CVS drugstores will begin selling Naloxone — an opioid-overdose reversal drug — without a prescription in Arizona, the company said Tuesday. Arizona Attorney General Mark Brnovich said he has been working with pharmacies to combat opiod addiction in Arizona. (Gundran, 5/23)

Health News Florida: Report: Fentanyl Now Florida’s Deadliest Drug 

A new report from Florida medical examiners finds fentanyl caused more deaths than any other drug in Florida last year. With fentanyl coming into the U.S. illegally in pill and powder form, it’s now being cut with heroin. (Aboraya, 5/23)

WABE: What Is 'Gray Death,' And How Does It Kill? 

Amid Georgia’s opioid problem, a new drug has entered the market. “Gray death,” a cocktail of several opioids, was reported to have claimed its first death in Georgia last week. Despite efforts to curtail the spread of opioids in the Southeast, drugs are getting even stronger and more deadly, according to Georgia Bureau of Investigation public affairs director Nelly Miles. (Such, 5/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF